President Joe Biden’s United States Department of Health and Human Services (HHS) on Thursday stopped executive orders from his predecessor designed to significantly lower prescription drug prices for Americans, including insulin and epinephrine.
The new administration will apparently re-evaluate the executive action from President Donald Trump toward the end of March. It remains unclear if it will be reinstated.
.png)
.png)
